These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38827306)

  • 1. Crizotinib inhibits the metabolism of tramadol by non-competitive suppressing the activities of CYP2D1 and CYP3A2.
    Gao N; Xu X; Ye F; Li XY; Lin C; Shen XW; Qian J
    PeerJ; 2024; 12():e17446. PubMed ID: 38827306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations.
    Niu L; Ding L; Lu C; Zuo F; Yao K; Xu S; Li W; Yang D; Xu X
    J Ethnopharmacol; 2016 Sep; 191():350-359. PubMed ID: 27318274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Crizotinib Auto-Inhibit CYP3A in vivo?
    Bland AR; Shrestha N; Rosengren RJ; Ashton JC
    Pharmacology; 2020; 105(11-12):715-718. PubMed ID: 32460299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in plasma pharmacokinetics and hepatic metabolism of geissoschizine methyl ether from Uncaria hook in rats.
    Kushida H; Matsumoto T; Ikarashi Y; Nishimura H; Yamamoto M
    J Ethnopharmacol; 2021 Jan; 264():113354. PubMed ID: 32898626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of CYP3A4 genetic polymorphism on crizotinib metabolism and drug-drug interactions.
    Wang J; Xu XY; Li XY; Luo JC; Zhang ZY; Chen J; Cai JP; Zhang LK; Qian JC
    Toxicol Appl Pharmacol; 2024 Aug; 489():117016. PubMed ID: 38925514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory Mechanisms of Myricetin on Human and Rat Liver Cytochrome P450 Enzymes.
    Lou D; Bao SS; Li YH; Lin QM; Yang SF; He JY
    Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):611-618. PubMed ID: 30825074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolites and metabolic pathways of mesaconitine in rat liver microsomal investigated by using UPLC-MS/MS method in vitro].
    Bi YF; Liu S; Zhang RX; Song FR; Liu ZQ
    Yao Xue Xue Bao; 2013 Dec; 48(12):1823-8. PubMed ID: 24689241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of apatinib on the pharmacokinetics of tramadol and O-desmethyltramadol in rats.
    Bao SS; Tang PF; Gao NY; Xiao ZX; Qian JC; Zheng L; Hu GX; Xu HH
    PeerJ; 2023; 11():e16051. PubMed ID: 37719112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herb-drug interaction between Styrax and warfarin: Molecular basis and mechanism.
    Zhang F; Huang J; He RJ; Wang L; Huo PC; Guan XQ; Fang SQ; Xiang YW; Jia SN; Ge GB
    Phytomedicine; 2020 Oct; 77():153287. PubMed ID: 32739573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory effects of shikonin and β,β-dimethylacrylshikonin on tramadol metabolism in vitro and in vivo.
    Jin M; Shi D; Jin H; Zhou Z; Wang C
    J Pharm Pharmacol; 2020 Sep; 72(9):1232-1238. PubMed ID: 32424860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Avitinib on CYP450 Enzyme Activity in vitro and in vivo in Rats.
    Shi Y; Meng D; Wang S; Geng P; Xu T; Zhou Q; Zhou Y; Li W; Chen X
    Drug Des Devel Ther; 2021; 15():3661-3673. PubMed ID: 34456561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and effect of para-toluene-sulfonamide on rat liver microsomal cytochrome P450 from in vivo and in vitro studies.
    Zhou JQ; Tang ZQ; Zhang JN; Tang JC
    Acta Pharmacol Sin; 2006 May; 27(5):635-40. PubMed ID: 16626521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The exposure of highly toxic aconitine does not significantly impact the activity and expression of cytochrome P450 3A in rats determined by a novel ultra performance liquid chromatography-tandem mass spectrometric method of a specific probe buspirone.
    Zhu L; Yang X; Zhou J; Tang L; Xia B; Hu M; Zhou F; Liu Z
    Food Chem Toxicol; 2013 Jan; 51():396-403. PubMed ID: 23085095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation potential effects of Picroside II on cytochrome P450 enzymes in vitro and in vivo.
    Zhou N; Zhu Y; Hu M; Zheng R; Sun M; Bian Y; Chen X; Li T
    J Ethnopharmacol; 2023 Oct; 314():116582. PubMed ID: 37192720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Ecstasy influence on tramadol and its main metabolite plasma concentration in rats.
    Jamali B; Sheikholeslami B; Hosseinzadeh Ardakani Y; Lavasani H; Rouini MR
    Drug Metab Pers Ther; 2017 Sep; 32(3):137-145. PubMed ID: 28917081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsomal cytochrome P450 levels and activities of isolated rat livers perfused with albumin.
    Vuppugalla R; Shah RB; Chimalakonda AP; Fisher CW; Mehvar R
    Pharm Res; 2003 Jan; 20(1):81-8. PubMed ID: 12608540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Effects of Ibuprofen, Remdesivir and Omeprazole on Dexamethasone Metabolism in Control Sprague Dawley Male Rat Liver Microsomes (Drugs Often Used Together Alongside COVID-19 Treatment).
    Hussain A; Naughton DP; Barker J
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of crizotinib-midazolam interaction using the Simcyp population-based simulator: comparison of CYP3A time-dependent inhibition between human liver microsomes versus hepatocytes.
    Mao J; Johnson TR; Shen Z; Yamazaki S
    Drug Metab Dispos; 2013 Feb; 41(2):343-52. PubMed ID: 23129213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro metabolism of specific CYP2D and CYP3A opioid substrates using rat liver S9 fractions and mass spectrometry reveal a severe metabolic impairment with increasing age.
    Salmin SF; Giroux MC; Vachon P; Beaudry F
    Biomed Chromatogr; 2017 Feb; 31(2):. PubMed ID: 27390106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of rat cytochrome P450 3A and 2C isoforms are increased in vivo by magnesium sulfate as evidenced by enhanced oxidation of bupivacaine and testosterone in liver microsomes.
    Saito M; Okutomi T; Shimizu M; Matsumoto Y; Yamazaki H; Hoka S
    Drug Metab Pharmacokinet; 2006 Jun; 21(3):201-7. PubMed ID: 16858123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.